High to moderate penetrant mutations in breast cancer predisposition genes, such as BRCA1 and BRCA2, are rare in large populations and account for only 5–10% of total breast cancer cases (Carroll et al. 2008; Economopoulou et al. 2015). This evidence concerns the gene BRCA2 and breast cancer.